These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17140371)

  • 41. Multiple sclerosis: interferon beta for some serious forms.
    Prescrire Int; 2007 Dec; 16(92):252-7. PubMed ID: 18092425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current status of gene expression profiling in the diagnosis and management of acute leukaemia.
    Bacher U; Kohlmann A; Haferlach T
    Br J Haematol; 2009 Jun; 145(5):555-68. PubMed ID: 19344393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy.
    Wakabayashi T; Natsume A; Hashizume Y; Fujii M; Mizuno M; Yoshida J
    J Gene Med; 2008 Apr; 10(4):329-39. PubMed ID: 18220319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects.
    Tian Y; Apperson ML; Ander BP; Liu D; Stomova BS; Jickling GC; Enriquez R; Agius MA; Sharp FR
    J Neuroimmunol; 2011 Jan; 230(1-2):124-9. PubMed ID: 20920832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. From microarrays to mechanisms of brain development and function.
    Díaz E
    Biochem Biophys Res Commun; 2009 Jul; 385(2):129-31. PubMed ID: 19460360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene discovery in craniofacial development and disease--cashing in your chips.
    Handrigan GR; Buchtová M; Richman JM
    Clin Genet; 2007 Feb; 71(2):109-19. PubMed ID: 17250659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptional profiling of mesothelioma using microarrays.
    Gordon GJ
    Lung Cancer; 2005 Jul; 49 Suppl 1():S99-S103. PubMed ID: 15950812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene-expression profiling in epithelial ovarian cancer.
    Konstantinopoulos PA; Spentzos D; Cannistra SA
    Nat Clin Pract Oncol; 2008 Oct; 5(10):577-87. PubMed ID: 18648354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuromyelitis optica/Devic's disease: gene expression profiling of brain lesions.
    Satoh J; Obayashi S; Misawa T; Tabunoki H; Yamamura T; Arima K; Konno H
    Neuropathology; 2008 Dec; 28(6):561-76. PubMed ID: 18410276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The promise and peril of transcriptional profiling in biofilm communities.
    An D; Parsek MR
    Curr Opin Microbiol; 2007 Jun; 10(3):292-6. PubMed ID: 17573234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Profiling studies in ovarian cancer: a review.
    Fehrmann RS; Li XY; van der Zee AG; de Jong S; Te Meerman GJ; de Vries EG; Crijns AP
    Oncologist; 2007 Aug; 12(8):960-6. PubMed ID: 17766655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The application of microarray technology to neuropathology: cutting edge tool with clinical diagnostics potential or too much information?
    McShea A; Marlatt MW; Lee HG; Tarkowsky SM; Smit M; Smith MA
    J Neuropathol Exp Neurol; 2006 Nov; 65(11):1031-9. PubMed ID: 17086099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.
    Lim ET; Giovannoni G
    Expert Rev Neurother; 2005 May; 5(3):379-90. PubMed ID: 15938671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RNA stabilization of peripheral blood and profiling by bead chip analysis.
    Debey-Pascher S; Eggle D; Schultze JL
    Methods Mol Biol; 2009; 496():175-210. PubMed ID: 18839112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain on a chip: a method to detect novel neuroprotective candidate targets.
    Tang Y; Bernaudin M
    Methods Mol Biol; 2007; 399():153-66. PubMed ID: 18309931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA array/microarrays in oncological research with focus on pancreatic cancer.
    Baron A; Moore PS; Scarpa A
    Adv Clin Path; 2001 Oct; 5(4):115-20. PubMed ID: 17582935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The future of genomic profiling of neurological diseases using blood.
    Sharp FR; Xu H; Lit L; Walker W; Apperson M; Gilbert DL; Glauser TA; Wong B; Hershey A; Liu DZ; Pinter J; Zhan X; Liu X; Ran R
    Arch Neurol; 2006 Nov; 63(11):1529-36. PubMed ID: 17101821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapy monitoring in patients with multiple sclerosis based on transcriptomic analysis].
    Zettl UK; Goertsches RH
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S64-8. PubMed ID: 19685398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An array of possibilities for multiple sclerosis.
    Tompkins SM; Miller SD
    Nat Med; 2002 May; 8(5):451-3. PubMed ID: 11984584
    [No Abstract]   [Full Text] [Related]  

  • 60. Diagnostic and prognostic potential of gene microarrays in rheumatoid arthritis.
    Jarvis JN
    Expert Rev Mol Diagn; 2005 Sep; 5(5):655-9. PubMed ID: 16149869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.